by BASO | Aug 12, 2024 | BASO
You want more information on GLP-1 medicines like #Ozempic, #Saxenda, #Wegovy, or #Mounjaro and GLP-1 shortages? You’ve heard about the debate over diabetes medication being promoted to quickly shed pounds?Discover everything via this link, or watch the video....
by BASO | Aug 12, 2024 | BASO
Today, Prof. Dr. Bart Van der Schueren, President of BASO, shares why you should join us! Are you passionate about obesity, whether scientifically or clinically? Do you want to play a pivotal role in the scientific debate? Do you aspire to make a difference?...
by BASO | Jun 7, 2024 | BASO, News
Stop Stigmatization: Obesity is a Chronic Disease!Join over ten leading Flemish obesity experts as they explore the many facets of this complex chronic condition in the podcast series “Obesity: The Big Truth.” This podcast aims to share groundbreaking...
by BASO | Feb 7, 2024 | BASO
The prevalence of overweight and obesity poses a challenge for society. The latest data reveals that almost half (49.3%) of the adult population are living with overweight, while 15.9% are living with obesity. Forecasts for 2030 are alarming, with a predicted obesity...
by BASO | Sep 28, 2023 | BASO, News
In response to recent discussions concerning the use of Ozempic (semaglutide) for the treatment of obesity, the Belgian Association for the Study of Obesity would like to articulate its position on the matter. Attached, you will find our comprehensive response that...
by BASO | Sep 5, 2023 | BASO, News
Marking one year of COM-acknowledgment, The Obesity Clinic at UZ Leuven hosted a landmark event on March 4, 2023. The symposium explored the complexities of stepwise care in obesity management and featured notable speakers like Gert Van Assche, Hoofdarts at UZ Leuven,...
by BASO | Jun 15, 2023 | BASO, News
Wij verwijzen hiermee naar het schrijven van Novo Nordisk van 1 juni 2023 omtrent informatie verstrekt onder het gezag van het FAGG Rechtstreekse mededeling aan de gezondheidszorgbeoefenaars (DHCP) Saxenda® (liraglutide) oplossing voor injectie in voorgevulde pen...